中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Mingxian LIU)

1.Analysis of the clinical characteristics in nonalcoholic steatohepatitis

Mingxian LI ; Shangzhong LIU ; Jiaoyan CHEN

Chinese Journal of Primary Medicine and Pharmacy 2015;22(1):45-48

2.Study on extraction of coumarins in Angelica Dahurica by supercritical CO_2

Hongmei LIU ; Mingxian ZHANG ; Yangping LIU ; Yongping HAN ; Fengyun TAO ;

Chinese Traditional Patent Medicine 1992;0(02):-

3.Clinical study of osteoporosis in patients with liver cirrhosis following hepatitis B virus infection

Yiguo WANG ; Qian LIU ; Wenqi WANG ; Ziping CHEN ; Mingxian YAN

Chinese Journal of General Practitioners 2002;0(01):-

4.Development of a portable automatic hemostatic instrument of extremities

Mingxian GUO ; Shipei CHEN ; Donghuan LIU ; Xijing JING ; Zhengkui GUO ; Yan CUI

Chinese Medical Equipment Journal 2003;0(12):-

5.Experience about Application of Risk Management in High-alert Medications in Ward Area of Our Hospital

Tongxia XIA ; Xiaolan LUO ; Yuhe WANG ; Mingxian LIU ; Lingxia SUN ; Linyu LI

China Pharmacy 2005;0(17):-

6.Statistics and Analysis of 136 Cases of Adverse Events of International Medical Devices.

Fei ZHAO ; Mingxian GAO ; Pu LIU ; Yang WANG ; Hangyao ZHANG ; Yuye ZHANG ; Qin ZHAN ; Shouli WANG

Chinese Journal of Medical Instrumentation 2020;44(2):166-171

7.SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling.

Liang XU ; Peixue LI ; Xue HAO ; Yi LU ; Mingxian LIU ; Wenqian SONG ; Lin SHAN ; Jiao YU ; Hongyu DING ; Shishuang CHEN ; Ailing YANG ; Yi Arial ZENG ; Lei ZHANG ; Hai JIANG

Protein & Cell 2021;12(3):174-193

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO